Wolsink Axel, Cliteur Maaike P, van Asch Charlotte J, Boogaarts Hieronymus D, Dammers Ruben, Hannink Gerjon, Schreuder Floris H B M, Klijn Catharina J M
Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, the Netherlands.
Stichting Epilepsie Instellingen Nederland (SEIN), Dr. Denekampweg 20, 8025 BV, Zwolle, the Netherlands.
Lancet Reg Health Eur. 2024 Dec 13;49:101180. doi: 10.1016/j.lanepe.2024.101180. eCollection 2025 Feb.
Intracerebral haemorrhage (ICH) accounts for approximately 28% of all strokes worldwide. ICH has a high case fatality, and only few survivors recover to independent living. Over the past decades, demographic changes, and changes in prevalence and management of risk factors may have influenced incidence. Widespread implementation of stroke units and improved care in general may have affected case fatality and outcome. We aimed to update the evidence on incidence, case fatality, and functional outcome of ICH, according to age, sex, and country income level.
We systematically searched PubMed and Embase from 2008 to April 2023 for prospective population-based studies on incidence, case fatality, or functional outcome of first-ever ICH. We excluded studies in which less than 80% of cases was confirmed with imaging or autopsy. Quality of the studies was assessed based on the used case finding methods. We used inverse variance-based random-effects meta-analyses to pool the crude incidence, case fatality at 1 month, and the percentage of patients with good functional outcome after 3, 6, or 12 months, as defined by the authors of the individual studies. Time trends were assessed using weighted linear meta-regression. Funnel plots were constructed to study publication bias. The review was registered on PROSPERO (CRD42023413314).
We identified 70 eligible studies, describing 19,470 ICH patients from 26 different countries. Of these, 62 studies reported on crude incidence, 41 on case fatality, and 10 on functional outcome. Overall crude incidence was 29.2 per 100,000 person-years (95% CI 23.3-36.4; I = 100%). Incidence was lower in women than in men and increased with age. Incidence was highest in lower-middle income countries, followed by high and upper-middle income countries. Case fatality at 1 month was 35.5% (95% CI 32.3-38.9; I = 90%). The percentage of patients with good functional outcome (mRS 0-2 in nine studies, mRS 0-3 in one) after 3-12 months was 31.2% (95% CI 24.7-38.6; I = 76%). We found no time trends in incidence, case fatality, or functional outcome.
Our results demonstrate the persistently high burden and devastating consequences of ICH, stressing the need for better preventive strategies and acute treatments.
None.
脑出血(ICH)约占全球所有中风病例的28%。脑出血的病死率很高,只有少数幸存者能够恢复到独立生活状态。在过去几十年中,人口结构变化以及危险因素患病率和管理方式的改变可能影响了发病率。中风单元的广泛实施和整体护理的改善可能影响了病死率和预后。我们旨在根据年龄、性别和国家收入水平,更新关于脑出血发病率、病死率和功能预后的证据。
我们系统检索了2008年至2023年4月期间PubMed和Embase数据库中基于人群的首次脑出血发病率、病死率或功能预后的前瞻性研究。我们排除了病例确诊率低于80%(通过影像学或尸检)的研究。根据所使用的病例发现方法评估研究质量。我们使用基于逆方差的随机效应荟萃分析,汇总粗发病率、1个月时的病死率以及各研究作者定义的3、6或12个月后功能预后良好患者的百分比。使用加权线性荟萃回归评估时间趋势。构建漏斗图以研究发表偏倚。该综述已在PROSPERO(CRD42023413314)上注册。
我们确定了70项符合条件的研究,描述了来自26个不同国家的19470例脑出血患者。其中,62项研究报告了粗发病率,41项报告了病死率,10项报告了功能预后。总体粗发病率为每10万人年29.2例(95%CI 23.3 - 36.4;I² = 100%)。女性发病率低于男性,且随年龄增长而增加。发病率在中低收入国家最高,其次是高收入和中高收入国家。1个月时的病死率为35.5%(95%CI 32.3 - 38.9;I² = 90%)。3至12个月后功能预后良好(9项研究中改良Rankin量表[mRS]评分为0 - 2,1项研究中为mRS 0 - 3)的患者百分比为31.2%(95%CI 24.7 - 38.6;I² = 76%)。我们未发现发病率、病死率或功能预后的时间趋势。
我们的结果表明脑出血的负担持续居高不下且后果严重,强调需要更好的预防策略和急性治疗方法。
无。